Apollomics Inc

Biotech Stocks Healthcare Stocks

$23.40

+6.03 (+34.72%)

As of Aug 14, 10:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -47.1% upside

Low Target $7.78

Average Target $12.39

High Target $16.73

Current Price $23.40

Current
$23.40

Target
$12.39

$7.78 $12.39 avg $16.73

Scenario Analysis

Bear Case

$7.78

-66.8%

Low target

Base Case

$12.39

-47.1%

Avg target

Bull Case

$16.73

+-28.5%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$42.12

-44.4% from high

52-Week Low

$3.66

+539.5% from low

Target vs 52W High

$12.39

-70.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%